Inflammation modulators

Details Inflammation modulators Inflammation modulators

2007-02-13

2007-02-13

Wilson, James O. (Department: 1624)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C546S155000

Reexamination Certificate

active

10314428

ABSTRACT:
Compounds, compositions and methods that are useful in the treatment of inflammatory, immunoregulatory, metabolic and cell proliferative conditions or diseases are provided herein. In particular, the invention provides compounds which modulate the expression and/or function of proteins involved in inflammation, metabolism and cell proliferation. The subject compounds contain quinoline or quinazoline rings.

REFERENCES:
patent: 3340260 (1967-09-01), Blatter
patent: 3705898 (1972-12-01), Alalmo
patent: 4433150 (1984-02-01), Champseix et al.
patent: 6184226 (2001-02-01), Chakravarty
patent: 21 06 510 (1971-08-01), None
patent: 22 22 231 (1974-06-01), None
patent: 28 26 526 (1979-01-01), None
patent: 0 579 496 (1994-01-01), None
patent: WO 99/01441 (1999-01-01), None
patent: WO 01/00610 (2001-01-01), None
patent: WO 01/30774 (2001-05-01), None
patent: WO 01/58890 (2001-08-01), None
patent: WO 01/68648 (2001-09-01), None
patent: WO 01/83456 (2001-11-01), None
patent: WO 01/90074 (2001-11-01), None
patent: WO 02/24679 (2002-03-01), None
patent: WO 02/28837 (2002-04-01), None
patent: WO 02/28860 (2002-04-01), None
patent: WO 02/30353 (2002-04-01), None
patent: WO 02/30423 (2002-04-01), None
patent: WO 02/41843 (2002-05-01), None
patent: WO 02/44153 (2002-06-01), None
patent: WO 02/46171 (2002-06-01), None
patent: WO 02/060386 (2002-08-01), None
patent: WO 02/076985 (2002-10-01), None
Kulkarni et al. “tynthesis, reactions, mass sprectra and biological evaluation of some new 4-aryloxymethylcarbostyrils”, Journal of the Indian Chemical Society, 1996, 73(9), 495-496.
Pavlova et al., “Synthesis and anti-inflammatory and anagesic activity . . . ”, Pharmaceutical Chemistry Journal, 1999, 33(8), 419-420.
El Bednary et al., Boll. Chim. Farm. 135(11):617-20 (1996); & Database Crossfire Beilstein [Online]; Beilstein Institut zur Forderung der Chemischen Wissenschaften, Frankfurt am Main, DE; retrieved from XFIRE, Accession No. 7798089.
Khazan et al., “Synthesis of substituted 2-(1-methyl-2-imidazolyl)quinolines” J. Heterocyclic Chem. 34:1543-47 (1997).
Lee, S. et al., “Discovery of potent cyclic GMP phosphodiesterase inhibitors. 2-pyridyl-and 2-imidazolylquinazolines possessing cyclic GMP phosphodiesterase and thromboxane synthesis inhibitory activities” J. Med. Chem. 38(18):3547-3557 (1995).
Patterson et al., “A new synthesis of N-substituted-2-alkyl(or aryl)quinazolin-4-amines by amide base-mediated cyclization of carboximidamides derived from 2-(trifluoromethyl)benzeneamine” H. Heterocyclic Chem. 29:703-706 (1992).
Strekowski, L. et al., “Synthesis and quantitative structure-activity relationship analysis of 2-(aryl or heteroaryl)quinolin-4-amines, a new class of anti-HIV-1 agents” J. Med. Chem. 34(5):1739-1746 (1991).
van Muijlwijk-Koezen et al., “Isoquinoline and quinazoline urea analogues as antagonists for the human adenosine A3receptor” J. Med. Chem. 43(5):2227-2338 (2000).

Affiliated with

Also associated with

Rating

Inflammation modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inflammation modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inflammation modulators will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3871100